{"retracted":false,"update":{"timestamp":1455580800000,"doi":"10.1007/s10549-016-3702-6","type":"correction"},"doi":"10.1007/s10549-012-2079-4","journal":"Breast Cancer Research and Treatment","publisher":"Springer Nature","title":"Erratum to: Inhibition of BRCT(BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal therapeutic option"}
